関連する実験動画
Updated: Feb 16, 2026

09:18
Measuring Diurnal Rhythms in Autophagic and Proteasomal Flux
Published on: September 17, 2019
5.1K
ミコバクテリアのプロテアソームとヒトのプロテアソームを選択的に抑制する
Gang Lin1, Dongyang Li, Luiz Pedro Sorio de Carvalho
1Department of Microbiology and Immunology, Weill Cornell Medical College, New York, New York 10065, USA. gal2005@med.cornell.edu
Nature
|September 18, 2009
まとめ
新しいオクサチアゾル-2-オンの化合物は,Mycobacterium tuberculosisのプロテアソームを選択的に阻害し,複製しない細菌を殺します. この発見は,タンパク質の分解経路をターゲットにすることで,結核に対する新しい戦略を提供します.
科学分野:
- バイオケミストリー バイオケミストリー
- 微生物学 微生物学とは
- ドラッグ・ディスカバリー・ドリッグ・ディスカバリー・ドリッグ・ディスカバリー・ドリッグ・ディスカバリー
背景:
- ほとんどの抗感染症薬は,細菌のタンパク質合成を標的とし,複製する病原体を殺します.
- 細菌のタンパク質の分解や不複製の病原体を標的とする薬はほとんどありません.
- 選択的プロテアソーム阻害剤は,新しい抗感染戦略に必要である.
研究 の 目的:
- Mycobacterium tuberculosisのプロテアソームの選択的阻害剤を特定するために.
- タンパク質の分解を標的とした代替の抗感染アプローチを探求する.
主な方法:
- プロテアソーム阻害のためのオクサチアゾル-2-オンの化合物のスクリーニング.
- M. tuberculosisのプロテアゾームの抑制メカニズムを調査する.
- M. tuberculosisとヒトプロテアソームに対する阻害剤の効能を比較する.
主要な成果:
- 特定のオクサチアゾル-2-オンの化合物は,M. tuberculosisのプロテアソームを選択的に阻害する.
- これらの化合物は,自殺基板阻害剤として作用し,プロテアソームを不可逆的にブロックします.
- 阻害剤の効能は,M. tuberculosisのプロテアゾーム活性部位の外にある保存されていない残留物と関連しており,ヒトの同類体を逃している.
結論:
- オキサチアゾル-2-オンの化合物は,有望な抗結核剤の新クラスを表しています.
- 選択的プロテアソーム阻害は,複製しないMycobacterium tuberculosisに対する実行可能な戦略を提供します.
- 必須酵素の保存されても保存されていない領域をターゲットにすることで,選択的な治療法が得られます.
関連する概念動画
The Proteasome
10.3K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
10.3K
The Proteasome
1.7K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.7K
The Proteasome
4.7K
No description available
4.7K
The Proteasome Structure
1.8K
The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
The proteasome is an...
1.8K
Eukaryotic Transcription Inhibitors
11.1K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.1K
What is Natural Selection?
129.9K
Natural selection is an evolutionary process in which individuals with survival-promoting traits reproduce at higher rates. These favorable traits become more common within a population or species. Naturally selected traits initially arise via random genetic mutations. In order for selection to occur, there must be variation within a population, the trait controlling the variation must be heritable, and there must be an evolutionary advantage for variation in the trait.
129.9K

